Stay up-to-date with advances in chronic kidney disease (CKD)! Join our esteemed Chief of Nephrology at Kashlak Memorial Hospital, Dr. Joel Topf, as he leads us through the latest on SGLT2 inhibitors, finerenone, potassium binders, and treatment of CKD-associated metabolic acidosis. Claim free CME for this episode at curbsiders.vcuhealth.org! Episodes | Subscribe | Spotify | YouTube | Mailing List | [email protected] | Swag! | Free CME! Show Segments Intro, disclaimer, guest bio Case from Kashlak SGLT2i: when to initiate SGLT2i: adverse effects Finerenone Potassium binders Treatment of CKD-associated metabolic acidosis Outro Credits Writer, Producer, Show Notes, Infographics, and Cover Art: Malini Gandhi Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP Reviewer: Leah Witt MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Dr. Joel Topf MD Sponsor: Better Help Visit betterhelp.com/curb today to get 10% off your first month. Sponsor: Birch Living Birch is giving 20% off all mattresses and 2 free eco-rest pillows at birchliving.com/curb. Sponsor: PanaceaFinancial Visit panaceafinancial.com to open a free account. Full transcript available HERE

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related